Abstract
Background
Lymphoepithelial-like carcinoma is a rare tumour type. The optimal treatment for this disease is not known. No effective therapies are described in the literature.
Aims
This report describes a case of lymphoepithelial-like carcinoma and documents a therapeutic strategy which has proved effective.
Results
The patient was initially treated with a common platinum-based chemotherapy regimen incorporating a taxane (Carbplatin and Docetaxel). Disease stabilization initially occurred but the patient soon progressed. The patient was then treated with VIP chemotherapy and had a complete response.
Conclusion
VIP chemotherapy appears to be an effective therapeutic strategy in lymphoepithelial-like carcinoma.
Similar content being viewed by others
References
Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelial-like carcinomas.Am J Clin Pathol 1995; 103:308–315
Tseng TJ, Pao CC, Tseng LH, et al. Lymphoepithelial-like carcinoma of the uterinr cervix: association with Epstein-Barr virus and human papillomavirus.Cancer 1997;80:91–97.
Chen FF, Yan JJ, Lai WW, Jin YT, Su IJ. Epstein-Barr virus associated non-small lung carcinoma: undifferentiated ‘lymphoepithelial-like’ carcinoma as a distinct entity with better prognosis.Cancer 1998;82:2334–2342.
Lind AC, Breer WA, Wick MR. Lymphoepithelial-like carcinoma of the skin with apparent origin in the epidermis — a pattern or an entity? A case report.Cancer 1999;85:884–890.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Duffy, A.G., Wyse, G., Morgan, A.M. et al. Taxane-resistant lymphoepithelial-like carcinoma: Excellent response to VIP chemotherapy. Ir J Med Sci 175, 64–65 (2006). https://doi.org/10.1007/BF03169176
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03169176